Comparative mutagenicity of 7H-dibenzo[c,g]carbazole and two derivatives in Muta™Mouse liver and skin

被引:20
作者
Renault, D
Tombolan, F
Brault, D
Périn, F
Thybaud, V
机构
[1] Rhone Poulenc Sante, Drug Safety Dept, F-94403 Vitry Sur Seine, France
[2] CNRS, UPR 42, F-94801 Villejuif, France
[3] Inst Curie, Rech, F-91405 Orsay, France
关键词
transgenic mouse; Muta (TM) Mouse; liver; skin; dibenzocarbazole;
D O I
10.1016/S1383-5718(98)00101-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
7H-Dibenzo[c,g]carbazole (DBC) is an environmental pollutant that produces DNA adducts and tumors in mouse liver and skin following subcutaneous injection and topical application. The two synthetic derivatives 5,9-dimethyl-DBC (DMDBC) and N7-methyl-DBC (NMDBC) induce tissue-specific lesions. DNA adducts and tumors are observed only in liver following exposure to DMDBC and only in skin following exposure to NMDBC. We used the positive selection Muta(TM)Mouse model to measure the induction of mutations in the two target organs, 28 days after a single subcutaneous injection or topical application of DEC, DMDBC and NMDBC. In liver, DEC and DMDBC induced 30- to 50-fold increases in mutant frequency (MF), while NMDBC had only a weak effect, regardless of the route of administration. After topical application, DEC and NMDBC produced 3.4- to 7.9-fold increases in MF in skin, while DMDBC had a weak effect. After subcutaneous injection, the three compounds had no or weak effect in skin. This study shows gene mutations arise in the respective target organs in which primary DNA damage and tumors are observed. These results illustrate the relevance of the Muta(TM)Mouse model for testing organ-specific mutagens. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:129 / 140
页数:12
相关论文
共 43 条
[1]   CORRELATION OF CARCINOGENIC POTENCY WITH MOUSE-SKIN P-32 POSTLABELING AND MUTA-RMOUSE LAC Z- MUTATION DATA FOR DMBA AND ITS K-REGION SULFUR ISOSTERE - COMPARISON WITH ACTIVITIES OBSERVED IN STANDARD GENOTOXICITY ASSAYS [J].
ASHBY, J ;
BRUSICK, D ;
MYHR, BC ;
JONES, NJ ;
PARRY, JM ;
NESNOW, S ;
PATON, D ;
TINWELL, H ;
ROSENKRANZ, HS ;
CURTI, S ;
GILMAN, D ;
CALLANDER, RD .
MUTATION RESEARCH, 1993, 292 (01) :25-40
[2]   Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons [J].
Boffetta, P ;
Jourenkova, N ;
Gustavsson, P .
CANCER CAUSES & CONTROL, 1997, 8 (03) :444-472
[3]   Tissue-specific induction of mutations by acute oral administration of N-methyl-N'-nitro-N-nitrosoguanidine and beta-propiolactone to the Muta(TM)Mouse: Preliminary data on stomach, liver and bone marrow [J].
Brault, D ;
Bouilly, C ;
Renault, D ;
Thybaud, V .
MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS, 1996, 360 (02) :83-87
[4]   Detection of gene mutation in skin, stomach and liver of Muta(TM)Mouse following oral or topical treatment with N-methyl-N'-nitro-N-nitrosoguanidine or 1-chloromethylpyrene: Some preliminary observations [J].
Brooks, TM ;
Dean, SW .
MUTAGENESIS, 1996, 11 (05) :529-532
[5]   A STRATEGY FOR ESTABLISHING MODE OF ACTION OF CHEMICAL CARCINOGENS AS A GUIDE FOR APPROACHES TO RISK ASSESSMENTS [J].
BUTTERWORTH, BE ;
CONOLLY, RB ;
MORGAN, KT .
CANCER LETTERS, 1995, 93 (01) :129-146
[6]   TRANSGENIC LAMBDA/LACI MUTAGENICITY ASSAY - STATISTICAL DETERMINATION OF SAMPLE-SIZE [J].
CALLAHAN, JD ;
SHORT, JM .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 327 (1-2) :201-208
[7]   Cell proliferation as a determining factor for the carcinogenicity of chemicals: Studies with mutagenic carcinogens and mutagenic noncarcinogens [J].
Cunningham, ML ;
Matthews, HB .
TOXICOLOGY LETTERS, 1995, 82-3 :9-14
[8]   Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens [J].
Cunningham, ML .
MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY, 1996, 365 (1-3) :59-69
[9]  
Douglas GR, 1996, ENVIRON MOL MUTAGEN, V28, P317
[10]  
Gabelova A, 1997, ENVIRON MOL MUTAGEN, V30, P56, DOI 10.1002/(SICI)1098-2280(1997)30:1<56::AID-EM8>3.0.CO